Similar results have been documented in other types of cancer, where PTEN loss was associated with increased aggressiveness, metastasis, and poorer prognosis (breast cancer [14], ovarian cancer [15] and hepatocellular carcinoma [16]). Here, PTEN is linked to breast cancer.